Horizon Pharma Buys Raptor to Boost Rare Disease Portfolio

The deal includes PROCYSBI delayed-release capsules and QUINSAIR (aerosolized form of levofloxacin) global rights
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news